Autres langues Hemostemix Inc.

Actions

HEM

CA4236943060

Temps Différé Toronto S.E. Autres places de cotation 21:54:26 01/05/2024			Varia. 5j.	Varia. 1 janv.
0,035 ^CAD	-12,50%		-22,22%	-50,00%

30/04	Hemostemix Inc. présente ses résultats pour l'année complète terminée le 31 décembre 2023	CI
06/02	Hemostemix annonce la mise à jour des résultats de l'essai clinique randomisé de phase II publiés par le Journal of Biomedical Research and Environmental Sciences	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Hemostemix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
Hemostemix Announces Engagement of Oak Hill Asset Management Inc.	07/03
Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences	06/02
Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences	06/02
Hemostemix Clarifies its October 3, 2023 News Release	29/12
Hemostemix Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/11
Hemostemix Inc. Announces That 4Th Heart Study Published in Stem Cell Research & Therapy Confirms Treatment for Heart Disease	31/10/23
Hemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease	30/10/23
Hemostemix Announces Amendment of its $2.5 Million 5 Year Convertible Debenture Issued on June 11, 2021, Resulting in an Expected Interest Saving of Approximately $570,000	23/10/23
Hemostemix Closed Private Placement	03/10/23
Hemostemix Closed $320,125 Private Placement	03/10/23
Hemostemix Inc. announced that it has received CAD 0.320385 million in funding	03/10/23
Hemostemix Inc. announced that it expects to receive CAD 0.325125 million in funding	28/09/23
Hemostemix Announces Private Placement	27/09/23
Hemostemix Inc. announced that it has received CAD 0.72754 million in funding	27/09/23
Hemostemix Inc. Announces Its Study of NCP-01 Supporting Brain Computer Interfaces Has Been Submitted for Peer Review Publication	15/09/23
Hemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant Applications	30/08/23
Hemostemix Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/08/23
Hemostemix Announces Arbitration Award of CAD $315,684 Plus Private Placement	15/08/23
Hemostemix Inc. Submits its Retrospective Heart Study to Leading Stem Cell Journal	10/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Hemostemix Inc.

Actions

HEM

CA4236943060

Autres langues

Filtres